GERMANY DISAGREES WITH U.S. ON COVID-19 VACCINE PATIENT RIGHTS.

By ESOSA OMOROGBE.



Germany and the United States of America could not have an agreement  over the patient rights for the vaccine developed by a German biotech firm.

United States' President, Donald Trump had reportedly offered the sum of "one billion dollars" to secure a patient rights into the research to produce a vaccine by German biotech firm CureVac


Germany’s foreign minister said Monday the rights to coronavirus vaccine research were not for sale, as against Donald Trump's intention for US to buy exclusive access to a potential vaccine developed by a German biotech firm as  scientists raced to develop a vaccine against the deadly coronavirus that has killed some 6,000 people, seen millions placed under lockdown and devastated global markets.

“German researchers play a leading role in drug and vaccine development and we cannot allow others to seek exclusive results,” Heiko Maas was quoted as saying.
#SPARKNEWSNAIJA.(SNN).